The Effect of PinnoThin on Satiety and Food Intake

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01034605

Acronym

PinnoThin

Enrollment

Registered

2009-12-17

Start date

2008-12-31

Completion date

2010-01-31

Last updated

2012-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Based upon an increased secretion of gastrointestinal satiety hormones (CCK, GLP-1), PinnoThin is hypothesized to be more satiating, and to limit energy intake in humans. Therefore, the objective of this study is to investigate whether PinnoThin leads to an increase in satiety as determined by VAS ratings? Additionally, does PinnoThin consumed during breakfast, in comparison to placebo, in overweight women, lead to a decrease in energy intake during an ad libitum lunch?

Interventions

DIETARY_SUPPLEMENTPinnoThin

6.0 gram of the oil extract from the korean pine nut (PinnoThin) as a single dose

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* age over 18 and under 45 * women * BMI over 23 and under 30 * breakfast eaters

Exclusion criteria

* men * age under 18 and over 45 * BMI under 23 and over 30 * use of medication * pregnant and breastfeeding

Design outcomes

Primary

Measure	Time frame
appetite profile ratings	10 timepoints

Secondary

Measure	Time frame
energy intake	3.5 hours after PinnoThin

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026